Document is current
Any future updates will be listed below
-
Authors
Chan, Wai Cheung https://orcid.org/0000-0001-8413-5401
Liu, Xiaoxi
Magin, Robert S.
Girardi, Nicholas M.
Ficarro, Scott B.
Hu, Wanyi
Tarazona Guzman, Maria I.
Starnbach, Cara A.
Felix, Alejandra
Adelmant, Guillaume https://orcid.org/0000-0003-4075-5486
Varca, Anthony C.
Hu, Bin https://orcid.org/0000-0002-9212-0776
Bratt, Ariana S.
DaSilva, Ethan
Schauer, Nathan J.
Jaen Maisonet, Isabella
Dolen, Emma K. https://orcid.org/0000-0002-4653-4054
Ayala, Anthony X.
Marto, Jarrod A. https://orcid.org/0000-0003-2086-1134
Buhrlage, Sara J. https://orcid.org/0000-0003-4562-1823
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health
Massachusetts Life Sciences Center
Mark Foundation for Cancer Research, Ellison Foundation
- License Information
-
More Information
Article History
Received: 22 December 2021
Accepted: 20 January 2023
First Online: 8 February 2023
Competing interests
: J.A.M. is a founder, equity holder, and advisor to Entact Bio, serves on the SAB of 908 Devices, and receives sponsored research funding from Vertex, AstraZeneca, Taiho, Springworks and TUO Therapeutics. S.J.B. is a founder, equity holder, and advisor to Entact Bio and serves on the SAB of Adenoid Cystic Carcinoma Foundation. S.J.B. currently receives funding from AbbVie and Tuo Therapeutics, and has received in-kind services from AbbVie and Novartis Institutes for Biomedical Research during the past 24 months. The remaining authors declare no competing interests.
